About: Omeprazole and CYP2C19 polymorphism: effects of long-term treatment on gastrin, pepsinogen I, and chromogranin A in patients with acid related disorders

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Omeprazole and CYP2C19 polymorphism: effects of long-term treatment on gastrin, pepsinogen I, and chromogranin A in patients with acid related disorders Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 November 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в листопаді 2000 (uk) im November 2000 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en payares de 2000 (ast) scientific article published on 01 November 2000 (en)
publication date	wds:Q73166746-1A9B0A5B-1E04-4D98-917B-314A814EC152
publication date	2000-11-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q73166746-06B13CFA-08B6-41C1-A873-C422993FB8A5 wds:Q73166746-7684E069-BFA5-4619-A308-BDC4B4F8B586 wds:Q73166746-7D4B7AF9-BF33-4595-B96A-07745BFB8FB4 wds:Q73166746-9B4B6095-116D-4175-AACB-1C6C1E3CB3D7 wds:Q73166746-C2152DAA-CE63-47B6-8D45-5248509EB171 wds:Q73166746-C2F1360E-99E1-4E0C-938E-8BFA0425599A
author name string	M Stridsberg L Bertilsson R Seensalu M Sagar A Kjellin S Mârdh
rdfs:label	Omeprazole and CYP2C19 polymorphism: effects of long-term treatment on gastrin, pepsinogen I, and chromogranin A in patients with acid related disorders (en) Omeprazole and CYP2C19 polymorphism: effects of long-term treatment on gastrin, pepsinogen I, and chromogranin A in patients with acid related disorders (nl)
skos:prefLabel	Omeprazole and CYP2C19 polymorphism: effects of long-term treatment on gastrin, pepsinogen I, and chromogranin A in patients with acid related disorders (en) Omeprazole and CYP2C19 polymorphism: effects of long-term treatment on gastrin, pepsinogen I, and chromogranin A in patients with acid related disorders (nl)
name	Omeprazole and CYP2C19 polymorphism: effects of long-term treatment on gastrin, pepsinogen I, and chromogranin A in patients with acid related disorders (en) Omeprazole and CYP2C19 polymorphism: effects of long-term treatment on gastrin, pepsinogen I, and chromogranin A in patients with acid related disorders (nl)
title	wds:Q73166746-EDB08EA3-A01F-4B72-AF6C-786D08234EDE
title	Omeprazole and CYP2C19 polymorphism: effects of long-term treatment on gastrin, pepsinogen I, and chromogranin A in patients with acid related disorders (en)
page(s)	wds:Q73166746-15843D12-1AB8-4EF9-8FA9-B49C415E1050
page(s)	1495-1502
instance of	wds:Q73166746-444F3505-6D3A-437E-8955-B8D6A60DE4CF
instance of	scholarly article
main subject	wds:Q73166746-2184529A-C93B-4403-9A34-BD1848C83061
main subject	omeprazole
PubMed ID	wds:Q73166746-56723420-FEC2-466E-96FC-FD3CAF33D405
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11069321
PubMed ID	11069321
published in	wds:Q73166746-B610FCA1-1DD0-4B60-9CC3-5F6480DE266B
published in	Alimentary Pharmacology & Therapeutics
issue	wds:Q73166746-AF19E559-AA9E-4218-903B-B6D29C66951C
volume	wds:Q73166746-CD5F30D0-F062-4FF0-8611-1A0123937BB5
issue	11
volume	14
DOI	wds:Q73166746-51C4E051-F671-4C39-AE56-7B5C234C44AE
DOI	http://dx.doi.org/10.1046/J.1365-2036.2000.00835.X
DOI	10.1046/J.1365-2036.2000.00835.X
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73166746
is cites work of	Pathogenesis of Helicobacter pylori infection Pharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapy Genetic factors in the pathogenesis of gastroesophageal reflux disease Clinical significance of the cytochrome P450 2C19 genetic polymorphism Pharmacokinetics of proton pump inhibitors in children Treatment of acid-related diseases in the elderly with emphasis on the use of proton pump inhibitors CYP2C19 pharmacogenetics in the clinical use of proton-pump inhibitors for gastro-oesophageal reflux disease: variant alleles predict gastric acid suppression, but not oesophageal acid exposure or reflux symptoms A randomized, double-blind trial of the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg omeprazole in the maintenance of gastro-oesophageal reflux disease over 5 years Individualized therapy for gastroesophageal reflux disease: potential impact of pharmacogenetic testing based on CYP2C19. Effects of the Proton Pump Inhibitors Omeprazole and Pantoprazole on the Cytochrome P450-Mediated Metabolism of Venlafaxine.
is cites work of	wds:Q44299604-24C9AD8C-D283-4959-AE2D-174C7DED9582 wds:Q35031744-653A2CF6-3B3C-408A-B519-50F16E86FA3D wds:Q36116456-34F3E515-793A-4B5D-A04F-1281960BE59B wds:Q28201086-854AB2DE-D7A7-4EE3-9563-A53A2E114630 wds:Q24676890-2DB3C8F4-BA58-4E8E-9F34-6C0C9AD4B99A wds:Q38032920-3A2BB4FB-581A-4197-88E0-BD909F38130E wds:Q24679810-C0AA80E2-60F1-46AE-8717-0FBA51C0E699 wds:Q73566543-AEE9FFEC-ACB4-4267-95E5-284DEFD4C1F0 wds:Q37874455-5CCF9200-B0E7-4C04-A2D7-A5A6A05B8783 wds:Q48129123-A3DC82B8-25E4-44B9-A718-7D507E4939B9

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software